drugset / Trial / NCT00003076
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
Phase 2
Completed
152 enrolled
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI) · collab
Prevention
Summary
RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer in patients with Barrett's esophagus. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine in preventing cancer in patients with Barrett's esophagus.
Timeline
- Start
- 1995-10
- Primary completion
- 2002-06
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eflornithine | Small molecule | — | Oral |